nocodazole has been researched along with masoprocol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Hatsuzawa, K; Itoh, H; Nagahama, M; Tagaya, M; Tani, K; Yamaguchi, T | 1 |
Fukunaga, T; Hatsuzawa, K; Nagahama, M; Tagaya, M; Tani, K; Yamamoto, A | 1 |
Kono, Y; Kuroiwa, N; Nakamura, M; Takatsuki, A | 1 |
Batenburg, JJ; Haagsman, HP; ten Brinke, A; Vaandrager, AB; van Golde, LM | 1 |
Kono, Y; Nakamura, M; Takatsuki, A | 2 |
8 other study(ies) available for nocodazole and masoprocol
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Regulation of the golgi structure by the alpha subunits of heterotrimeric G proteins.
Topics: Animals; Biological Transport; Brefeldin A; Cell Line; Cell Membrane; Cyclooxygenase Inhibitors; Endoplasmic Reticulum; Golgi Apparatus; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gi-Go; Heterotrimeric GTP-Binding Proteins; Masoprocol; Nocodazole; Protein Synthesis Inhibitors; Proto-Oncogene Proteins | 2000 |
Implication of sphingolipid metabolism in the stability of the Golgi apparatus.
Topics: Animals; Brefeldin A; Cattle; Cell Line; Ceramides; Coat Protein Complex I; Endocannabinoids; Endosomes; Enzyme Inhibitors; Ethanolamines; Golgi Apparatus; Masoprocol; Microscopy, Electron; Morpholines; Nocodazole; Oleic Acids; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingosine; trans-Golgi Network | 2000 |
Glucosylceramide synthesis inhibitors block pharmacologically induced dispersal of the Golgi and anterograde membrane flow from the endoplasmic reticulum: implication of sphingolipid metabolism in maintenance of the Golgi architecture and anterograde memb
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Brefeldin A; Cell Line; Cell Membrane; Endoplasmic Reticulum; Enzyme Inhibitors; Fluorescent Dyes; Glucosylceramides; Golgi Apparatus; Lipoxygenase Inhibitors; Masoprocol; Microscopy, Fluorescence; Microtubules; Morpholines; Nocodazole; Rats; Sphingolipids | 2001 |
Differential effect of brefeldin A on the palmitoylation of surfactant protein C proprotein mutants.
Topics: Alanine; Animals; Antioxidants; Brefeldin A; Cell Membrane; Cell Nucleus; CHO Cells; Cricetinae; Cysteine; Immunohistochemistry; Kinetics; Leucine; Masoprocol; Monensin; Mutation; Nocodazole; Palmitic Acid; Palmitic Acids; Peptides; Proline; Protein Processing, Post-Translational; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Pulmonary Surfactants; Recombinant Proteins; Transfection | 2002 |
Possible implication of Golgi-nucleating function for the centrosome.
Topics: Animals; Arachidonic Acids; Autoantigens; Biological Transport; Brefeldin A; Cell Line; Centrosome; Endoplasmic Reticulum; Enzyme Inhibitors; Glycoproteins; Golgi Apparatus; Golgi Matrix Proteins; Masoprocol; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Microtubules; Mitosis; Morpholines; Nocodazole; Phosphoprotein Phosphatases; Protein Kinase Inhibitors | 2002 |
Mepanipyrim, a novel inhibitor of pharmacologically induced Golgi dispersion.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Brefeldin A; Carrier Proteins; Cells, Cultured; Dose-Response Relationship, Drug; Fluorescent Dyes; Fungicides, Industrial; Humans; Masoprocol; Mice; Microscopy, Fluorescence; Microtubules; Nocodazole; Oligosaccharides; Pyrimidines; trans-Golgi Network | 2003 |